Tuesday, 18 February 2020

China News

  • QIAGEN gets SFDA's nod for careHPV Test

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: QIAGEN announced that China's State Food and Drug Administration (SFDA) has approved QIAGEN's careHPV Test and instrument platform. The careHPV Test is the first molecular diagn...Read more

  • Stem cell therapy to treat liver cirrhosis

    China |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jul, 2012

    Singapore: A study conducted by Beike Biotechnology Company in conjunction with physicians and researchers at two Chinese hospitals, has highlighted the effectiveness of cord blood-derived ...Read more

  • Lilly strengthens its foothold in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, June 15, 2012:  In support of its commitment to maximize growth opportunities in China, Eli Lilly has plans to increase its network of manufacturing capabilities in the country ...Read more

  • GlobalData: Osteoporosis market to be $8 bn

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 08 Mar, 2013

    Singapore: According to GlobalData, the osteoporosis therapeutics market of the US, France, Germany, Italy, Spain, the UK, Japan, China, and India will reach a value of $8 billion in 2022 ...Read more

  • Quintiles deepens investment in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, June 18, 2012: CRO leading company, Quintiles plans to establish a Quintiles regional headquarters for China in Shanghai and to significantly expand lab testing capabilities in C...Read more

  • MedImmune and WuXi AppTec Announce Joint Venture to Develop Novel Biologic

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, a leading research and development outsourcing company, have formed a joint venture to develop and commercia...Read more

  • Bal Seal expands in China to tap into growing medical industry

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Responding to predicted growth in China's medical industry, Bal Seal Engineering, a leading provider of custom-engineered sealing, connecting, conducting and EMI shielding compo...Read more

  • APAC ovarian cancer drug market to grow modestly'

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 30 Jan, 2015

    Singapore: Asia Pacific (APAC) therapeutics market for ovarian cancer will undergo a modest rise in value, from $294.3 million in 2013 to $417.6 million by 2020, at a Compound Annual Growth...Read more

  • China Botanic reports Q3 2012 results

    China |  Company results | By BioSpectrum Bureau  | 0 Comment | 21 Sep, 2012

    Singapore: China Botanic Pharmaceutical revealed its financial results for the three months ending July 31, 2012. During the third quarter (Q3) of fisal year 2012, net revenue increased by ...Read more

  • Golden Meditech Acquires Convertible Notes to Increase Stake in Hospital Management Business

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Golden Meditech Holdings, together with its subsidiaries, a leading integrated healthcare enterprise in China, is increasing its ownership in hospital management business by acq...Read more

  • Research and Markets offers new report on China pharma industry

    China |  News | By BioSpectrum Bureau  | 0 Comment | 14 May, 2012

    Singapore: Research and Markets has added a report on China Pharmaceutical Machinery Industry to their offering. This report first gives an overview of the pharmaceutical machinery industr...Read more

  • China Biologics appoint David Gao to additional post of CEO

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    China Biologic Products, one of the leading plasma-based biopharmaceutical companies in the People's Republic of China, has appointed Chairman Mr David (Xiaoying) Gao to the additional pos...Read more

  • BMS pledges $15 million to help curb diabetes in India and China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: The Bristol-Myers Squibb Foundation has expanded its Together on Diabetes initiative to China and India, pledging $15 million over five years to help these developing nations wit...Read more

  • Genetic diagnostics companies speed ahead

    China |  Opinion | By Nandita Singh | 0 Comment | 28 Jun, 2013

    The playing field for research and development for genetic diagnostics has been leveled. The landmark decision by the US Supreme Court on June 13, 2013, stating that human genes cannot be p...Read more

  • Bristol-Myers Squibb reveals new grants for Hepatitis in India, China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore, July 30, 2012: The Bristol-Myers Squibb Foundation has awarded four new grants totaling US $1.69 million to improve prevention, care and support of hepatitis B (HBV) and hepatiti...Read more

  • Tiyanyin pharma all set for GMP inspection

    China |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: China-based Tianyin Pharmaceutical is looking ahead to get its Qionglai Facility (QLF) GMP certified post insepction by China Food and Drug Administration (CFDA) expected to begi...Read more

  • Industry applauds Dr Weidong Yin

    China |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2012

    "I met Dr Weidong Yin for the first time in 1996 when I went to Tangshan, China. At that time, he was involved in research. He was very young then and was running a very small scale company...Read more

  • Simcere, Zhuhai enter share transfer agreement

    China |  News | By BioSpectrum Bureau  | 0 Comment | 26 Jun, 2013

    Singapore: Leading pharmaceutical company, Simcere Pharmaceutical, announced sale of equity interest in Jilin Bodapharmaceutical (Boda). The company entered into a share transfer agreement ...Read more